A citation-based method for searching scientific literature

Annette Haacke, F Ulrich Hartl, Peter Breuer. J Biol Chem 2007
Times Cited: 67



Ludger Schöls, Peter Bauer, Thorsten Schmidt, Thorsten Schulte, Olaf Riess. Lancet Neurol 2004
Times Cited: 649




List of shared articles



Times cited


Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Carlos A Matos, Sandra de Macedo-Ribeiro, Ana Luísa Carvalho. Prog Neurobiol 2011
88

Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).
Jeannette Hübener, Jonasz Jeremiasz Weber, Claudia Richter, Lisa Honold, Andreas Weiss, Fabronia Murad, Peter Breuer, Ullrich Wüllner, Peter Bellstedt, Francois Paquet-Durand,[...]. Hum Mol Genet 2013
51

Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.
Polina A Egorova, Ilya B Bezprozvanny. FEBS J 2018
22

Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.
Polina Egorova, Elena Popugaeva, Ilya Bezprozvanny. Semin Cell Dev Biol 2015
34

Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.
Carlos A Matos, Luís Pereira de Almeida, Clévio Nóbrega. J Neurochem 2019
37


Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease.
Ana Teresa Simões, Nélio Gonçalves, Rui Jorge Nobre, Carlos Bandeira Duarte, Luís Pereira de Almeida. Hum Mol Genet 2014
34

Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).
Francesca Prestori, Francesco Moccia, Egidio D'Angelo. Int J Mol Sci 2019
7

Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.
Maria do Carmo Costa, Naila S Ashraf, Svetlana Fischer, Yemen Yang, Emily Schapka, Gnanada Joshi, Thomas J McQuade, Rahil M Dharia, Mark Dulchavsky, Michelle Ouyang,[...]. Brain 2016
24

Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways.
Andreia Teixeira-Castro, Michael Ailion, Ana Jalles, Heather R Brignull, João L Vilaça, Nuno Dias, Pedro Rodrigues, João F Oliveira, Andreia Neves-Carvalho, Richard I Morimoto,[...]. Hum Mol Genet 2011
66

Therapeutic prospects for spinocerebellar ataxia type 2 and 3.
Ilya Bezprozvanny, Thomas Klockgether. Drugs Future 2009
13

Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.
Marina P Hommersom, Ronald A M Buijsen, Willeke M C van Roon-Mom, Bart P C van de Warrenburg, Hans van Bokhoven. Stem Cell Rev Rep 2021
0


Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
153

Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.
Sofia Esteves, Sara Duarte-Silva, Patrícia Maciel. Med Res Rev 2017
11

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
37

Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.
Carlos A Matos, Luis Pereira de Almeida, Clevio Nobrega. Curr Pharm Des 2017
14